These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32936048)

  • 1. Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia.
    Helal MA; Shouman S; Abdelwaly A; Elmehrath AO; Essawy M; Sayed SM; Saleh AH; El-Badri N
    J Biomol Struct Dyn; 2022 Feb; 40(3):1109-1119. PubMed ID: 32936048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
    Ragotte RJ; Pulido D; Donnellan FR; Hill ML; Gorini G; Davies H; Brun J; McHugh K; King LDW; Skinner K; Miura K; Long CA; Zitzmann N; Draper SJ
    mSphere; 2021 Aug; 6(4):e0064721. PubMed ID: 34378982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
    Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
    Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Modeling of T Cell Hypersensitivity during Coronavirus Infections Leading to Autoimmunity and Lethality.
    Celebi AT; Uzel G; Oylumlu E; Baykasoglu C; Mugan A; Joly S; Ciraci C
    Comput Math Methods Med; 2022; 2022():9444502. PubMed ID: 35341005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD147 as an alternative binding site for the spike protein on the surface of SARS-CoV-2.
    Faghihi H
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):11992-11994. PubMed ID: 33336782
    [No Abstract]   [Full Text] [Related]  

  • 6. No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor.
    Shilts J; Crozier TWM; Greenwood EJD; Lehner PJ; Wright GJ
    Sci Rep; 2021 Jan; 11(1):413. PubMed ID: 33432067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2-associated lymphopenia: possible mechanisms and the role of CD147.
    Shouman S; El-Kholy N; Hussien AE; El-Derby AM; Magdy S; Abou-Shanab AM; Elmehrath AO; Abdelwaly A; Helal M; El-Badri N
    Cell Commun Signal; 2024 Jul; 22(1):349. PubMed ID: 38965547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathway enrichment analysis of virus-host interactome and prioritization of novel compounds targeting the spike glycoprotein receptor binding domain-human angiotensin-converting enzyme 2 interface to combat SARS-CoV-2.
    Gollapalli P; B S S; Rimac H; Patil P; Nalilu SK; Kandagalla S; Shetty P
    J Biomol Struct Dyn; 2022 Apr; 40(6):2701-2714. PubMed ID: 33146070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD147 as a Target for COVID-19 Treatment: Suggested Effects of Azithromycin and Stem Cell Engagement.
    Ulrich H; Pillat MM
    Stem Cell Rev Rep; 2020 Jun; 16(3):434-440. PubMed ID: 32307653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an
    Pandey P; Rane JS; Chatterjee A; Kumar A; Khan R; Prakash A; Ray S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6306-6316. PubMed ID: 32698689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method.
    Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT
    Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor markers as an entry for SARS-CoV-2 infection?
    Xia P; Dubrovska A
    FEBS J; 2020 Sep; 287(17):3677-3680. PubMed ID: 32738184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Binding Affinity of Omicron's Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence.
    Kumar R; Murugan NA; Srivastava V
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico binding profile characterization of SARS-CoV-2 spike protein and its mutants bound to human ACE2 receptor.
    Zhang Y; He X; Zhai J; Ji B; Man VH; Wang J
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34013346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Truncated human angiotensin converting enzyme 2; a potential inhibitor of SARS-CoV-2 spike glycoprotein and potent COVID-19 therapeutic agent.
    Basit A; Ali T; Rehman SU
    J Biomol Struct Dyn; 2021 Jul; 39(10):3605-3614. PubMed ID: 32396773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
    Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
    Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2.
    Celik I; Khan A; Dwivany FM; Fatimawali ; Wei DQ; Tallei TE
    Mol Divers; 2022 Dec; 26(6):3309-3324. PubMed ID: 35138508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential peptide inhibitor of SARS-CoV-2 S and human ACE2 complex.
    Jaiswal G; Yaduvanshi S; Kumar V
    J Biomol Struct Dyn; 2022 Sep; 40(14):6671-6681. PubMed ID: 33645443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.